Amphastar Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Amphastar Pharmaceuticals, Inc.‘s stocks are currently a part of 146 hedge funds’ portfolios, which represents 37.07% of the total amount of its stocks outstanding. This makes up a total of 19.43M shares of Amphastar Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -33.26% or -9.68M shares fewer. As for the holding position changes, 34.25% (50) of current hedge fund investors increased the number of shares held, 37.67% (55) of current holders sold a part of the shares held, and 11.64% (17) closed the holdings completely. 21 hedge funds are new holders of Amphastar Pharmaceuticals, Inc. stock in Q1 2023, it is 14.38% of total holders.
Hedge funds holding Amphastar Pharmaceuticals (Q2 2018 – Q1 2023)
Q2 2018 | 110 |
---|---|
Q3 2018 | 103 |
Q4 2018 | 131 |
Q1 2019 | 133 |
Q2 2019 | 128 |
Q3 2019 | 129 |
Q4 2019 | 114 |
Q1 2020 | 106 |
Q2 2020 | 131 |
Q3 2020 | 133 |
Q4 2020 | 126 |
Q1 2021 | 131 |
Q2 2021 | 142 |
Q3 2021 | 135 |
Q4 2021 | 165 |
Q1 2022 | 199 |
Q2 2022 | 215 |
Q3 2022 | 196 |
Q4 2022 | 204 |
Q1 2023 | 146 |
Hedge funds changes in Amphastar Pharmaceuticals positions (Q2 2018 – Q1 2023)
Q2 2018 | 13 | 40 | 37 | 16 | 4 |
---|---|---|---|---|---|
Q3 2018 | 8 | 42 | 32 | 14 | 7 |
Q4 2018 | 31 | 46 | 38 | 4 | 12 |
Q1 2019 | 19 | 59 | 38 | 16 | 1 |
Q2 2019 | 14 | 58 | 40 | 17 | -1 |
Q3 2019 | 18 | 45 | 49 | 16 | 1 |
Q4 2019 | 9 | 42 | 47 | 23 | -7 |
Q1 2020 | 10 | 39 | 35 | 16 | 6 |
Q2 2020 | 33 | 44 | 37 | 8 | 9 |
Q3 2020 | 18 | 54 | 38 | 15 | 8 |
Q4 2020 | 9 | 42 | 53 | 17 | 5 |
Q1 2021 | 18 | 42 | 51 | 12 | 8 |
Q2 2021 | 27 | 51 | 44 | 16 | 4 |
Q3 2021 | 11 | 50 | 51 | 16 | 7 |
Q4 2021 | 39 | 59 | 48 | 7 | 12 |
Q1 2022 | 55 | 68 | 59 | 20 | -3 |
Q2 2022 | 36 | 88 | 73 | 16 | 2 |
Q3 2022 | 17 | 80 | 78 | 36 | -15 |
Q4 2022 | 28 | 69 | 82 | 17 | 8 |
Q1 2023 | 21 | 50 | 55 | 17 | 3 |
Hedge funds changes in Amphastar Pharmaceuticals stock options (Q2 2018 – Q1 2023)
Q2 2018 | 0 | 154,000 |
---|---|---|
Q3 2018 | 0 | 0 |
Q4 2018 | 0 | 0 |
Q1 2019 | 221,000 | 0 |
Q2 2019 | 21,000 | 517,000 |
Q3 2019 | 19,000 | 496,000 |
Q4 2019 | 32,000 | 372,000 |
Q1 2020 | 0 | 160,000 |
Q2 2020 | 0 | 2,363,000 |
Q3 2020 | 203,000 | 1,106,000 |
Q4 2020 | 0 | 0 |
Q1 2021 | 0 | 429,000 |
Q2 2021 | 0 | 0 |
Q3 2021 | 0 | 0 |
Q4 2021 | 291,000 | 0 |
Q1 2022 | 2,661,000 | 37,621,000 |
Q2 2022 | 6,056,000 | 60,695,000 |
Q3 2022 | 2,768,000 | 935,000 |
Q4 2022 | 1,342,128 | 315,982 |
Q1 2023 | 52,000 | 18,000 |